ProKidney to Participate in TD Cowen’s 43rd Annual Health
WINSTON-SALEM, N.C., March 03, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late
Globe Newswire3-03-2023, 18:21
Jeito Capital leads a $105 million Series C financing in Alentis Therapeutics to advance transformational medicines for claudin-1 in cancer & fibrosis 13-04-2023, 12:15